Eisaku Nakamura
Director/Board Member at KUBOTA PHARMACEUTICAL HOLDINGS CO., LTD.
Profile
Eisaku Nakamura is currently an Independent Outside Director at D.
Western Therapeutics Institute, Inc. and Kubota Pharmaceutical Holdings Co. Ltd.
He is also an Auditor at KOINOBORI Associate, Inc. In the past, he worked as a Director at Acucela, Inc.
Eisaku Nakamura active positions
| Companies | Position | Start |
|---|---|---|
| KUBOTA PHARMACEUTICAL HOLDINGS CO., LTD. | Director/Board Member | 29/02/2016 |
| D. WESTERN THERAPEUTICS INSTITUTE, INC. | Director/Board Member | 28/03/2018 |
| KOINOBORI Associate, Inc. | Comptroller/Controller/Auditor | 31/12/2016 |
Former positions of Eisaku Nakamura
| Companies | Position | End |
|---|---|---|
| ACUCELA INC | Director/Board Member | - |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 2 |
|---|---|
| D. WESTERN THERAPEUTICS INSTITUTE, INC. | Health Technology |
| KUBOTA PHARMACEUTICAL HOLDINGS CO., LTD. | Health Technology |
| Private companies | 2 |
|---|---|
Acucela, Inc.
 Acucela, Inc. Pharmaceuticals: MajorHealth Technology Acucela, Inc. operates as a clinical-stage biotechnology company. It discovers and develops novel therapeutics to treat and show the progression of sight-threatening ophthalmic diseases. Its pipeline includes drug candidates and therapeutics for the treatment of age related macular degeneration, cataracts, presbyopia, diabetic retinopathy, retinitis igmentosa and Stargardt disease. The company was founded by Ryo Kubota in April 2002 and is headquartered in Seattle, WA. | Health Technology |
| KOINOBORI Associate, Inc. |
- Stock Market
- Insiders
- Eisaku Nakamura
